Cargando…
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
Replication‐incompetent adenovirus (Ad) vector and mRNA‐lipid nanoparticle (LNP) constructs represent two modular vaccine platforms that have attracted substantial interest over the past two decades. Due to the COVID‐19 pandemic and the rapid development of multiple successful vaccines based on thes...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877955/ https://www.ncbi.nlm.nih.gov/pubmed/36330560 http://dx.doi.org/10.1002/eji.202250022 |